People · Operator
Named in public records as an officer, director or promoter · active 2009–2013 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dimension Therapeutics, Inc. | — | Other Technology | Series C | $94.5M | $2.0B | 2013 |
| Zelos Therapeutics Inc | — | Pharmaceuticals | Series A | $17.8M | $75.0M | 2012 |
| Vitae Pharmaceuticals, Inc | — | Pharmaceuticals | Series A | $15.0M | $464.6M | 2009 |
Donald Hayden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Hayden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryan Roberts | 1 | 18 |
| Peter Barrett | 1 | 18 |
| Rishi Gupta | 1 | 12 |
| Annalisa Jenkins | 1 | 8 |
| Thomas Beck | 1 | 7 |
| Joseph Zakrzewski | 1 | 6 |
| James Tananbaum | 1 | 6 |
| Farah Champsi | 1 | 5 |
| Jay K. Hachigian | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Donald J. Hayden, Jr. | 1 | 5 |
| Brian MacDonald | 1 | 4 |
| Jaisim Shah | 1 | 3 |
| Alex Barkas | 1 | 3 |
| Jeff Courtney | 1 | 3 |
| Donald J Hayden | 1 | 3 |
| David Krause | 1 | 3 |
| Jeffrey Courtney | 1 | 2 |
| Benjamin Auspitz | 1 | 2 |
| Cynthia Lavoie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.